MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells.

Abstract:

:The large Maf family of basic leucine-zipper-containing transcription factors are known regulators of key developmental and functional processes in various cell types, including pancreatic islets. Here, we demonstrate that within the adult pancreas, MafB is only expressed in islet alpha-cells and contributes to cell type-specific expression of the glucagon gene through activation of a conserved control element found between nucleotides -77 to -51. MafB was also shown to be expressed in developing alpha- and beta-cells as well as in proliferating hormone-negative cells during pancreatogenesis. In addition, MafB expression is maintained in the insulin(+) and glucagon(+) cells remaining in mice lacking either the Pax4 or Pax6 developmental regulators, implicating a potentially early role for MafB in gene regulation during islet cell development. These results indicate that MafB is not only important to islet alpha-cell function but may also be involved in regulating genes required in both endocrine alpha- and beta-cell differentiation.

journal_name

Diabetes

journal_title

Diabetes

authors

Artner I,Le Lay J,Hang Y,Elghazi L,Schisler JC,Henderson E,Sosa-Pineda B,Stein R

doi

10.2337/diabetes.55.02.06.db05-0946

subject

Has Abstract

pub_date

2006-02-01 00:00:00

pages

297-304

issue

2

eissn

0012-1797

issn

1939-327X

pii

55/2/297

journal_volume

55

pub_type

杂志文章

相关文献

DIABETES文献大全
  • Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.

    abstract::Antibodies to islet cell proteins detected as 37,000 and 40,000 M(r), tryptic fragments (37- and 40-kDa antigens) are strongly associated with progression to IDDM. The 40-kDa antigen has recently been identified as the tyrosine phosphatase-like protein IA-2 (ICA512) whereas the 37-kDa antigen has been suggested to be ...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.45.9.1187

    authors: Hawkes CJ,Wasmeier C,Christie MR,Hutton JC

    更新日期:1996-09-01 00:00:00

  • The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function.

    abstract::The neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) is ubiquitously distributed in both the central and peripheral nervous systems and exerts a variety of effects. PACAP is a neuropeptide in pancreatic islets, where it has been suggested as a parasympathetic and sensory neurotransmitter. PACAP ...

    journal_title:Diabetes

    pub_type: 杂志文章,评审

    doi:10.2337/diabetes.50.9.1959

    authors: Filipsson K,Kvist-Reimer M,Ahrén B

    更新日期:2001-09-01 00:00:00

  • Effects of hyperinsulinemia in the primate fetus.

    abstract::Nonhuman primate models of gestational diabetes have produced fetopathies most similar to those of the human infant of the mother with gestational diabetes (IGDM). Fetal hyperglycemia, hyperinsulinemia, macrosomia, selective organomegaly, intrauterine death, and placental hyperplasia are hallmarks of the fetopathy of ...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.34.2.s36

    authors: Susa JB,Schwartz R

    更新日期:1985-06-01 00:00:00

  • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism.

    abstract::ATP-sensitive potassium (K[ATP]) channels are an essential component of glucose-dependent insulin secretion in pancreatic islet beta-cells. These channels comprise the sulfonylurea receptor (SUR1) and Kir6.2, a member of the inward rectifier K+ channel family. Mutations in the SUR1 subunit are associated with familial...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.46.11.1743

    authors: Nestorowicz A,Inagaki N,Gonoi T,Schoor KP,Wilson BA,Glaser B,Landau H,Stanley CA,Thornton PS,Seino S,Permutt MA

    更新日期:1997-11-01 00:00:00

  • Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians.

    abstract::The associations of the adiponectin (APM1) gene with parameters of the metabolic syndrome are inconsistent. We performed a systematic investigation based on fine-mapped single nucleotide polymorphisms (SNPs) highlighting the genetic architecture and their role in modulating adiponectin plasma concentrations in a parti...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diabetes.55.02.06.db05-0747

    authors: Heid IM,Wagner SA,Gohlke H,Iglseder B,Mueller JC,Cip P,Ladurner G,Reiter R,Stadlmayr A,Mackevics V,Illig T,Kronenberg F,Paulweber B

    更新日期:2006-02-01 00:00:00

  • Interaction of interleukin-1 with islet beta-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression.

    abstract::A 5-day culture of adult rat islets with human recombinant IL-1 beta (3 U/ml) resulted in the death of most alpha-cells and 50% of beta-cells. The IL-1--exposed islet tissue contained--in addition to poorly granulated beta-cells--patches of outgrowing monolayers and dispersed activated macrophages. In purified alpha- ...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.42.1.56

    authors: Ling Z,In't Veld PA,Pipeleers DG

    更新日期:1993-01-01 00:00:00

  • The influence of diabetes on the vasomotor responses of saphenous vein and the development of infra-inguinal vein graft stenosis.

    abstract::There has been a prejudice that diabetes modulates the function of saphenous vein in a manner that predisposes to bypass graft failure, although most of the evidence accrues from animal studies. We have investigated the effect of diabetes on the vasodilator responses and ultrastructure of saphenous vein harvested from...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.46.1.113

    authors: Hicks RC,Moss J,Higman DJ,Greenhalgh RM,Powell JT

    更新日期:1997-01-01 00:00:00

  • Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis.

    abstract::One hundred fifty-four selected patients with nonketotic diabetes diagnosed between the ages of 35 and 75 yr and treated with diet or oral hypoglycemic agents for at least 1 yr were investigated for parameters of glycemic control (weight loss, blood glucose, and glycosylated hemoglobin), islet cell function (fasting a...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.35.2.237

    authors: Groop LC,Bottazzo GF,Doniach D

    更新日期:1986-02-01 00:00:00

  • Kinetics of contraction-induced GLUT4 translocation in skeletal muscle fibers from living mice.

    abstract:OBJECTIVE:Exercise is an important strategy for the treatment of type 2 diabetes. This is due in part to an increase in glucose transport that occurs in the working skeletal muscles. Glucose transport is regulated by GLUT4 translocation in muscle, but the molecular machinery mediating this process is poorly understood....

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db10-0233

    authors: Lauritzen HP,Galbo H,Toyoda T,Goodyear LJ

    更新日期:2010-09-01 00:00:00

  • BB rat thymocytes cultured in the presence of islets lose their ability to transfer autoimmune diabetes.

    abstract::Thymocytes from adult BB rats can adoptively transfer autoimmune diabetes to athymic recipients. It is also known that the development of BB rat T-cells is recapitulated in adult thymus organ cultures (ATOCs). Based on these observations, we tested the hypothesis that cells capable of the adoptive transfer of diabetes...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diabetes.50.5.972

    authors: Whalen BJ,Marounek J,Weiser P,Appel MC,Greiner DL,Mordes JP,Rossini AA

    更新日期:2001-05-01 00:00:00

  • Impaired glucose-induced insulin response in transgenic mice overexpressing the L-phosphofructokinase gene.

    abstract::The selective impairment of glucose-induced insulin secretion in NIDDM can be attributed to defects in the glucose-signaling system. An alteration in the activity of phosphofructokinase (PFK), a key enzyme in the glycolytic pathway, may play a role in the abnormal glucose-induced insulin secretion. In this study, we e...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.46.9.1414

    authors: Knobler H,Weiss Y,Peled M,Groner Y

    更新日期:1997-09-01 00:00:00

  • Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study.

    abstract::Rosiglitazone therapy improves insulin sensitivity and glucose uptake in patients with uncomplicated type 2 diabetes. In coronary artery disease (CAD), glucose is an important source of energy and preserved myocardial glucose uptake is essential for the viability of jeopardized myocardium. The aim was to test whether ...

    journal_title:Diabetes

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2337/diabetes.54.9.2787

    authors: Lautamäki R,Airaksinen KE,Seppänen M,Toikka J,Luotolahti M,Ball E,Borra R,Härkönen R,Iozzo P,Stewart M,Knuuti J,Nuutila P

    更新日期:2005-09-01 00:00:00

  • Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.

    abstract::Ciglitazone, 5-[4-(1-methylcyclohexylmethoxy) benzyl]-thiazolidine-2,4-dione, is a new hypoglycemic agent orally active in the obese-hyperglycemic animal models. In C57BL/6J-ob/ob mice, treatment with 100 mg/kg ciglitazone for 2 days elicited a drastic fall in blood glucose. It also decreased plasma insulin, triglycer...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.32.9.830

    authors: Chang AY,Wyse BM,Gilchrist BJ,Peterson T,Diani AR

    更新日期:1983-09-01 00:00:00

  • Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?

    abstract::Widely held theories of the pathogenesis of obesity-associated NIDDM have implicated apparently incompatible events as seminal: 1) insulin resistance in muscle, 2) abnormal secretion of insulin, and 3) increases in intra-abdominal fat. Altered circulating or tissue lipids are characteristic features of obesity and NID...

    journal_title:Diabetes

    pub_type: 杂志文章,评审

    doi:10.2337/diab.45.3.273

    authors: Prentki M,Corkey BE

    更新日期:1996-03-01 00:00:00

  • The endothelium, triglyceride-rich lipoproteins, and atherosclerosis: insights from cell biology and lipid metabolism.

    abstract::Endothelial cells in culture retain many of the functional properties of the endothelium in vivo. At high cell density, they become contact-inhibited. Endothelial cells, like vascular smooth muscle cells and fibroblasts, express binding sites for low density lipoprotein when depleted of sterol. In contact-inhibited en...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.30.2.s19

    authors: Fielding CJ

    更新日期:1981-01-01 00:00:00

  • Insulin resistance caused by massive degradation of subcutaneous insulin.

    abstract::Severe resistance to subcutaneous insulin but sensitivity to intravenous insulin persisted for 15 months in a 17-year-old diabetic girl. Heat-labile insulin-degrading activity was present in the patient's ketotic sera and in the 100,000 g fraction (soluble fraction) of adipose tissue. Serum-degrading activity was not ...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.28.7.640

    authors: Paulsen EP,Courtney JW 3rd,Duckworth WC

    更新日期:1979-07-01 00:00:00

  • Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes.

    abstract::Although diabetes is the most common cause of end-stage renal disease (ESRD) worldwide, most people with diabetic nephropathy will never develop ESRD but will instead die of cardiovascular (CV) disease (CVD). The first evidence of kidney injury in diabetes is often microalbuminuria, itself also an independent risk mar...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db13-0795

    authors: Siddiqi FS,Advani A

    更新日期:2013-11-01 00:00:00

  • Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.

    abstract::We examined the effects of activation of peroxisome proliferator-activated receptor (PPAR)alpha, PPARgamma, and both of them in combination in obese diabetic KKAy mice and investigated the mechanisms by which they improve insulin sensitivity. PPARalpha activation by its agonist, Wy-14,643, as well as PPARgamma activat...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diabetes.54.12.3358

    authors: Tsuchida A,Yamauchi T,Takekawa S,Hada Y,Ito Y,Maki T,Kadowaki T

    更新日期:2005-12-01 00:00:00

  • Direct effects of glucagon on protein and amino acid metabolism in the isolated perfused rat liver. Interactions with insulin and dexamethasone in net synthesis of albumin and acute-phase proteins.

    abstract::The isolated rat liver perfused for 12 hours at pH 7.10 with a suspension of bovine erythrocytes in Krebs-Ringer bicarbonate buffer containing 3 per cent bovine serum albumin has been used as a test system to study effects of glucagon and of dexamethasone in the presence and absence of insulin on net biosynthesis of r...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:

    authors: Miller LL

    更新日期:1976-01-01 00:00:00

  • Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance.

    abstract::The aim of this study was to test the hypothesis that plasma leptin concentrations contributed to the pathophysiology of NIDDM by decreasing both insulin-mediated glucose disposal and glucose-stimulated insulin secretion. The study was performed in 60 women with normal oral glucose tolerance. Differences in insulin-me...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.47.2.244

    authors: Carantoni M,Abbasi F,Azhar S,Chen YD,Klebanov M,Wang PW,Warmerdam F,Reaven GM

    更新日期:1998-02-01 00:00:00

  • Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance.

    abstract::Munc13-1 is a diacylglycerol (DAG) receptor that is essential for synaptic vesicle priming. We recently showed that Munc13-1 is expressed in rodent and human islet beta-cells and that its levels are reduced in islets of type 2 diabetic humans and rat models, suggesting that Munc13-1 deficiency contributes to the abnor...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db05-1263

    authors: Kwan EP,Xie L,Sheu L,Nolan CJ,Prentki M,Betz A,Brose N,Gaisano HY

    更新日期:2006-05-01 00:00:00

  • No evidence of amyloidosis in type I diabetics treated with continuous subcutaneous insulin infusion.

    abstract::A recent study has demonstrated secondary amyloidosis in dogs treated with continuous intravenous insulin infusion. Since elevated levels of serum amyloid A protein (SAA) and diminished amyloid fibril degrading activity (AFDA) are associated with amyloidosis, we measured SAA and AFDA in ten type I diabetics treated wi...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.32.1.88

    authors: Koivisto VA,Teppo AM,Maury CP,Taskinen MR

    更新日期:1983-01-01 00:00:00

  • Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis.

    abstract::Recently, we identified in normally type 1 diabetes-prone NOD/LtJ mice a spontaneous new leptin receptor (LEPR) mutation (designated Lepr(db-5J)) producing juvenile obesity, hyperglycemia, hyperinsulinemia, and hyperleptinemia. This early type 2 diabetes syndrome suppressed intra-islet insulitis and permitted spontane...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:

    authors: Lee CH,Chen YG,Chen J,Reifsnyder PC,Serreze DV,Clare-Salzler M,Rodriguez M,Wasserfall C,Atkinson MA,Leiter EH

    更新日期:2006-01-01 00:00:00

  • Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis.

    abstract::The macro- and microvascular burden of type 2 diabetes is well established. A number of recent single risk factor intervention trials targeting hyperglycemia, dyslipidemia, hypertension, procoagulation, microalbumuria, and existing cardiovascular disorders have, however, shown major beneficial effects on long-term out...

    journal_title:Diabetes

    pub_type: 杂志文章,评审

    doi:10.2337/diabetes.53.suppl_3.s39

    authors: Gaede P,Pedersen O

    更新日期:2004-12-01 00:00:00

  • Enhanced NF-κB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes.

    abstract::Type 2 diabetes (T2D) is associated with vascular dysfunction. We hypothesized that increased nuclear factor-κB (NF-κB) signaling contributes to vascular dysfunction in T2D. We treated type 2 diabetic (db(-)/db(-)) and control (db(-)/db(+)) mice with two NF-κB inhibitors (6 mg/kg dehydroxymethylepoxyquinomicin twice a...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db12-1374

    authors: Kassan M,Choi SK,Galán M,Bishop A,Umezawa K,Trebak M,Belmadani S,Matrougui K

    更新日期:2013-06-01 00:00:00

  • Targeted inactivation of kinesin-1 in pancreatic β-cells in vivo leads to insulin secretory deficiency.

    abstract:OBJECTIVE:Suppression of Kinesin-1 by antisense oligonucleotides, or overexpression of dominant-negative acting kinesin heavy chain, has been reported to affect the sustained phase of glucose-stimulated insulin secretion in β-cells in vitro. In this study, we examined the in vivo physiological role of Kinesin-1 in β-ce...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db09-1078

    authors: Cui J,Wang Z,Cheng Q,Lin R,Zhang XM,Leung PS,Copeland NG,Jenkins NA,Yao KM,Huang JD

    更新日期:2011-01-01 00:00:00

  • Lung and Kidney ACE2 and TMPRSS2 in Renin Angiotensin System Blocker Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19.

    abstract::The causes of the increased risk of severe COVID-19 in persons with diabetes are unclear. It has been speculated that renin angiotensin system (RAS) blockers may promote COVID-19 by increasing ACE2, which SARS-CoV-2 uses to enter host cells, along with the host protease TMPRSS2. Taking a reverse translational approach...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/db20-0765

    authors: Batchu SN,Kaur H,Yerra VG,Advani SL,Kabir MG,Liu Y,Klein T,Advani A

    更新日期:2020-12-11 00:00:00

  • Progression of incipient diabetic retinopathy during good glycemic control.

    abstract::To assess the extent to which the progression of diabetic retinopathy can be arrested by improved glycemic control, 35 normal dogs were randomly divided into a nondiabetic and three alloxan-induced diabetic groups prospectively identified according to glycemic control: poor control for 5 yr (PC), good control for 5 yr...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.36.7.808

    authors: Engerman RL,Kern TS

    更新日期:1987-07-01 00:00:00

  • Wisconsin Epidemiologic Study of Diabetic Retinopathy. XII. Relationship of C-peptide and diabetic retinopathy.

    abstract::The relationship between plasma C-peptide and the frequency and severity of diabetic retinopathy was examined in a population-based study in Wisconsin in 1984-1986. Individuals with younger- (n = 835) and older- (n = 940) onset diabetes were included. C-peptide was measured by radioimmunoassay with Heding's M1230 anti...

    journal_title:Diabetes

    pub_type: 临床试验,杂志文章

    doi:10.2337/diab.39.11.1445

    authors: Klein R,Moss SE,Klein BE,Davis MD,DeMets DL

    更新日期:1990-11-01 00:00:00

  • Calcium-calmodulin-dependent myosin phosphorylation by pancreatic islets.

    abstract::Pancreatic islets contain enzyme activity which catalyzes the phosphorylation by MgATP of cardiac, skeletal, or smooth muscle myosin light chains. The enzyme is activated by calcium (Ka = 10 microM) and calmodulin (Ka = 2 nM) and inhibited by trifluoperazine (Ki = 10 microM), a known inhibitor of calmodulin and of ins...

    journal_title:Diabetes

    pub_type: 杂志文章

    doi:10.2337/diab.31.6.566

    authors: MacDonald MJ,Kowluru A

    更新日期:1982-06-01 00:00:00